arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1507.05935math.STstat.APstat.TH
收藏

多项试验的主要因果效应识别和替代终点评价

Principal causal effect identification and surrogate endpoint evaluation by multiple trials

Zhichao Jiang, Peng Ding, Zhi Geng

摘要:

主要分层是一个因果框架,用于分析随机实验,治疗后变量介于治疗和终点变量之间。由于由治疗后变量的潜在结局定义的主要分层不可观察,因此我们通常无法识别主要分层内的因果效应。出于一个真实的数据集的III期辅助结肠临床试验,我们提出的方法来确定和估计的主要因果关系,通过多个试验。对于可识别性,我们通过规定这些试验中的主要因果效应是同质的来删除常用的排除限制假设。为了消除另一个常用的单调性假设,我们给出了一个局部可识别的必要条件,这需要至少三次试验。将我们的方法应用于辅助结肠临床试验的数据,我们发现常用的单调性假设是站不住脚的,并且3年随访的无病生存率是5年随访的总生存率的有效替代终点,它满足因果必要性和因果充分性。我们还提出了一种基于贝叶斯分层模型的灵敏度分析方法,以研究偏离同质性假设的影响。

英文摘要:

Principal stratification is a causal framework to analyze randomized experiments with a post-treatment variable between the treatment and endpoint variables. Because the principal strata defined by the potential outcomes of the post-treatment variable are not observable, we generally cannot identify the causal effects within principal strata. Motivated by a real data set of phase III adjuvant colon clinical trials, we propose approaches to identifying and estimating the principal causal effects via multiple trials. For the identifiability, we remove the commonly-used exclusion restriction assumption by stipulating that the principal causal effects are homogeneous across these trials. To remove another commonly-used monotonicity assumption, we give a necessary condition for the local identifiability, which requires at least three trials. Applying our approaches to the data from adjuvant colon clinical trials, we find that the commonly-used monotonicity assumption is untenable, and disease-free survival with three-year follow-up is a valid surrogate endpoint for overall survival with five-year follow-up, which satisfies both the causal necessity and the causal sufficiency. We also propose a sensitivity analysis approach based on Bayesian hierarchical models to investigate the impact of the deviation from the homogeneity assumption.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑